226 related articles for article (PubMed ID: 15297486)
1. Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species.
Odds FC; Motyl M; Andrade R; Bille J; Cantón E; Cuenca-Estrella M; Davidson A; Durussel C; Ellis D; Foraker E; Fothergill AW; Ghannoum MA; Giacobbe RA; Gobernado M; Handke R; Laverdière M; Lee-Yang W; Merz WG; Ostrosky-Zeichner L; Pemán J; Perea S; Perfect JR; Pfaller MA; Proia L; Rex JH; Rinaldi MG; Rodriguez-Tudela JL; Schell WA; Shields C; Sutton DA; Verweij PE; Warnock DW
J Clin Microbiol; 2004 Aug; 42(8):3475-82. PubMed ID: 15297486
[TBL] [Abstract][Full Text] [Related]
2. Use of fluorescent probes to determine MICs of amphotericin B and caspofungin against Candida spp. and Aspergillus spp.
Peter J; Armstrong D; Lyman CA; Walsh TJ
J Clin Microbiol; 2005 Aug; 43(8):3788-92. PubMed ID: 16081911
[TBL] [Abstract][Full Text] [Related]
3. Further standardization of broth microdilution methodology for in vitro susceptibility testing of caspofungin against Candida species by use of an international collection of more than 3,000 clinical isolates.
Pfaller MA; Messer SA; Boyken L; Rice C; Tendolkar S; Hollis RJ; Diekema DJ
J Clin Microbiol; 2004 Jul; 42(7):3117-9. PubMed ID: 15243069
[TBL] [Abstract][Full Text] [Related]
4. In vitro activities of caspofungin compared with those of fluconazole and itraconazole against 3,959 clinical isolates of Candida spp., including 157 fluconazole-resistant isolates.
Pfaller MA; Diekema DJ; Messer SA; Hollis RJ; Jones RN
Antimicrob Agents Chemother; 2003 Mar; 47(3):1068-71. PubMed ID: 12604543
[TBL] [Abstract][Full Text] [Related]
5. Influences of methodological variables on susceptibility testing of caspofungin against Candida species and Aspergillus fumigatus.
Bartizal C; Odds FC
Antimicrob Agents Chemother; 2003 Jul; 47(7):2100-7. PubMed ID: 12821453
[TBL] [Abstract][Full Text] [Related]
6. Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp.
Messer SA; Diekema DJ; Boyken L; Tendolkar S; Hollis RJ; Pfaller MA
J Clin Microbiol; 2006 Feb; 44(2):324-6. PubMed ID: 16455878
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Etest method for determining caspofungin (MK-0991) susceptibilities of 726 clinical isolates of Candida species.
Pfaller MA; Messer SA; Mills K; Bolmström A; Jones RN
J Clin Microbiol; 2001 Dec; 39(12):4387-9. PubMed ID: 11724849
[TBL] [Abstract][Full Text] [Related]
8. Antifungal activity of micafungin against Candida and Aspergillus spp. isolated from pediatric patients in Japan.
Ikeda F; Saika T; Sato Y; Suzuki M; Hasegawa M; Mikawa T; Kobayashi I; Tsuji A
Med Mycol; 2009 Mar; 47(2):145-8. PubMed ID: 18668422
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of broth microdilution testing parameters and agar diffusion Etest procedure for testing susceptibilities of Aspergillus spp. to caspofungin acetate (MK-0991).
Espinel-Ingroff A
J Clin Microbiol; 2003 Jan; 41(1):403-9. PubMed ID: 12517880
[TBL] [Abstract][Full Text] [Related]
10. Caspofungin susceptibility testing of Candida inconspicua: correlation of different methods with the minimal fungicidal concentration.
Majoros L; Kardos G; Szabó B; Sipiczki M
Antimicrob Agents Chemother; 2005 Aug; 49(8):3486-8. PubMed ID: 16048965
[TBL] [Abstract][Full Text] [Related]
11. Time-kill studies investigating the killing activity of caspofungin against Candida dubliniensis: comparing RPMI-1640 and antibiotic medium 3.
Varga I; Sóczó G; Kardos G; Majoros L
J Antimicrob Chemother; 2008 Jul; 62(1):149-52. PubMed ID: 18390882
[TBL] [Abstract][Full Text] [Related]
12. New methods to assess susceptibilities of Aspergillus isolates to caspofungin.
Imhof A; Balajee SA; Marr KA
J Clin Microbiol; 2003 Dec; 41(12):5683-8. PubMed ID: 14662961
[TBL] [Abstract][Full Text] [Related]
13. Caspofungin activity against clinical isolates of fluconazole-resistant Candida.
Pfaller MA; Messer SA; Boyken L; Rice C; Tendolkar S; Hollis RJ; Diekema DJ
J Clin Microbiol; 2003 Dec; 41(12):5729-31. PubMed ID: 14662968
[TBL] [Abstract][Full Text] [Related]
14. Caspofungin susceptibility testing of isolates from patients with esophageal candidiasis or invasive candidiasis: relationship of MIC to treatment outcome.
Kartsonis N; Killar J; Mixson L; Hoe CM; Sable C; Bartizal K; Motyl M
Antimicrob Agents Chemother; 2005 Sep; 49(9):3616-23. PubMed ID: 16127030
[TBL] [Abstract][Full Text] [Related]
15. Multicenter comparison of the Sensititre YeastOne colorimetric antifungal panel with the NCCLS M27-A2 reference method for testing new antifungal agents against clinical isolates of Candida spp.
Espinel-Ingroff A; Pfaller M; Messer SA; Knapp CC; Holliday N; Killian SB
J Clin Microbiol; 2004 Feb; 42(2):718-21. PubMed ID: 14766842
[TBL] [Abstract][Full Text] [Related]
16. In vitro synergy of caspofungin and itraconazole against Aspergillus spp.: MIC versus minimal effective concentration end points.
Shalit I; Shadkchan Y; Samra Z; Osherov N
Antimicrob Agents Chemother; 2003 Apr; 47(4):1416-8. PubMed ID: 12654681
[TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibilities of Candida spp. to caspofungin: four years of global surveillance.
Pfaller MA; Boyken L; Hollis RJ; Messer SA; Tendolkar S; Diekema DJ
J Clin Microbiol; 2006 Mar; 44(3):760-3. PubMed ID: 16517851
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antibiotic Susceptibility Testing proposed standard and the E-test with the NCCLS broth microdilution method for voriconazole and caspofungin susceptibility testing of yeast species.
Chryssanthou E; Cuenca-Estrella M
J Clin Microbiol; 2002 Oct; 40(10):3841-4. PubMed ID: 12354895
[TBL] [Abstract][Full Text] [Related]
19. Multicenter comparison of the VITEK 2 yeast susceptibility test with the CLSI broth microdilution reference method for testing fluconazole against Candida spp.
Pfaller MA; Diekema DJ; Procop GW; Rinaldi MG
J Clin Microbiol; 2007 Mar; 45(3):796-802. PubMed ID: 17215344
[TBL] [Abstract][Full Text] [Related]
20. Correlation of Neo-Sensitabs tablet diffusion assay results on three different agar media with CLSI broth microdilution M27-A2 and disk diffusion M44-A results for testing susceptibilities of Candida spp. and Cryptococcus neoformans to amphotericin B, caspofungin, fluconazole, itraconazole, and voriconazole.
Espinel-Ingroff A; Canton E; Gibbs D; Wang A
J Clin Microbiol; 2007 Mar; 45(3):858-64. PubMed ID: 17215342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]